Mapping the causal landscape of polycystic ovary syndrome

Mendelian randomization (MR) studies have increasingly investigated potential predicted antecedents and consequences of polycystic ovary syndrome (PCOS), yet published evidence remains scattered across diverse exposures, outcomes, and analytical frameworks. This study aimed to systematically organize published PCOS-related MR evidence and develop an interactive platform to support evidence retrieval, comparison, and interpretation. We searched PubMed, Web of Science, Embase, and the Cochrane Library from inception to June 1, 2026. Original MR Studies were eligible if PCOS was either the exposure or the outcome, with extractable effect estimates. Each causal pathway was extracted separately for direction, definitions, effect estimates, primary MR method, Genome-Wide Association Study sources, ancestry, sample size, PCOS phenotype, sensitivity analyses, and sample overlap. Methodological appraisal followed Strengthening the Reporting of Observational Studies in Epidemiology-Mendelian Randomization. Evidence was summarized by direction, variable category, quality, and consistency. An interactive MR-PCOS Atlas was developed using R Shiny. Of 728 records identified, 306 original MR studies were included, yielding 1081 extractable causal pathways (763 with PCOS as outcome, 318 as exposure). Evidence concentrated in physiological traits and diseases/clinical phenotypes (312 and 299 pathways, respectively). Methodological quality was high in 13 studies, moderate in 279, and low in 14. Evidence most frequently addressed metabolic, endocrine, reproductive, and comorbidity pathways, while lifestyle, gut microbiota, immune phenotypes, and interventions remained limited. The MR-PCOS Atlas enables interactive browsing and comparison of published findings. This systematic synthesis provides a structured map of genetically supported PCOS associations and highlights areas of consistency, uncertainty, and methodological heterogeneity. Findings should be interpreted considering PCOS definitions, Genome-Wide Association Study sources, ancestry, and MR assumptions. The MR-PCOS Atlas serves as an evidence resource for retrieval and hypothesis generation, not for direct clinical recommendations.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-08-21
DOI
https://doi.org/10.1097/md.0000000000050366
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mapping the causal landscape of polycystic ovary syndrome

Junlin Zhou, Sanwei Du, Kexin Wang, Dandan Dai et al.
Medicine
Ovarian function and disorders
article

Mapping the causal landscape of polycystic ovary syndrome

Junlin Zhou, Sanwei Du, Kexin Wang, Dandan Dai, Wenhao Pan
article en

Abstract

Mendelian randomization (MR) studies have increasingly investigated potential predicted antecedents and consequences of polycystic ovary syndrome (PCOS), yet published evidence remains scattered across diverse exposures, outcomes, and analytical frameworks. This study aimed to systematically organize published PCOS-related MR evidence and develop an interactive platform to support evidence retrieval, comparison, and interpretation. We searched PubMed, Web of Science, Embase, and the Cochrane Library from inception to June 1, 2026. Original MR Studies were eligible if PCOS was either the exposure or the outcome, with extractable effect estimates. Each causal pathway was extracted separately for direction, definitions, effect estimates, primary MR method, Genome-Wide Association Study sources, ancestry, sample size, PCOS phenotype, sensitivity analyses, and sample overlap. Methodological appraisal followed Strengthening the Reporting of Observational Studies in Epidemiology-Mendelian Randomization. Evidence was summarized by direction, variable category, quality, and consistency. An interactive MR-PCOS Atlas was developed using R Shiny. Of 728 records identified, 306 original MR studies were included, yielding 1081 extractable causal pathways (763 with PCOS as outcome, 318 as exposure). Evidence concentrated in physiological traits and diseases/clinical phenotypes (312 and 299 pathways, respectively). Methodological quality was high in 13 studies, moderate in 279, and low in 14. Evidence most frequently addressed metabolic, endocrine, reproductive, and comorbidity pathways, while lifestyle, gut microbiota, immune phenotypes, and interventions remained limited. The MR-PCOS Atlas enables interactive browsing and comparison of published findings. This systematic synthesis provides a structured map of genetically supported PCOS associations and highlights areas of consistency, uncertainty, and methodological heterogeneity. Findings should be interpreted considering PCOS definitions, Genome-Wide Association Study sources, ancestry, and MR assumptions. The MR-PCOS Atlas serves as an evidence resource for retrieval and hypothesis generation, not for direct clinical recommendations.

MedicineVol. 105(34)
Guangzhou University of Chinese Medicine (CN), Dongguan University of Technology (CN), First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN), Chinese University of Hong Kong, Shenzhen (CN), Dongguan People’s Hospital (CN)
Good health and well-being
Openalex Percentile: Top 8%
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.